{
  "ptid_time": "037_S_4071_2011-09-29",
  "img_path": "/data/qiuhui/data/adni/images/037_S_4071/2011-09-29/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 105,998 mm³, 125.4% above the reference mean. With a Z-score of 3.64 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 7,360 mm³, 5.6% above the reference mean. With a Z-score of 0.49 (68.6th percentile), this represents normal volume ; whole brain volume measures 1,167,170 mm³, 13.4% above the reference mean. With a Z-score of 1.76 (96.1th percentile), this represents moderate enlargement; entorhinal cortex volume measures 4,477 mm³, 12.8% above the reference mean. With a Z-score of 0.84 (79.9th percentile), this represents normal volume ; fusiform gyrus volume measures 17,358 mm³, 3.9% below the reference mean. With a Z-score of -0.34 (36.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,115 mm³, 14.6% above the reference mean. With a Z-score of 1.31 (90.5th percentile), this represents mild enlargement. ",
  "text_data": "Age is 84.5 years. Gender is Male. Education: 13 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 24.0. Logical Memory: 10.0. Laboratory findings: Alkaline Phosphatase: 113.00 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 701.30 pg/mL (normal ); Total tau: 374.90 pg/mL (moderate elevated); Phosphorylated tau: 33.30 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.64), which is a strong indicator of brain atrophy, but hippocampal and entorhinal cortex volumes are normal. The MMSE score of 24 suggests mild cognitive impairment, while Aβ is normal but T-tau and P-tau are moderately elevated, suggesting possible neurodegeneration without amyloid pathology (e.g., primary age-related tauopathy or PART).  \n\n**Diagnosis:** **MCI** (likely non-amnestic or non-AD etiology given preserved hippocampal volume and normal Aβ)  \n**Confidence:** **Medium** (ventricular enlargement and tau elevation support neurodegeneration, but normal Aβ and hippocampal volume complicate a definitive AD diagnosis)",
  "timestamp": "2025-07-26T06:41:00.736810"
}